Article

Endocrine Case Report: Thumb Swelling and Redness

Our latest case report from Brady Pregerson, MD, featuresa woman in her mid-60s with a history of Hashimoto’s thyroiditis treated with levothyroxine presenting to the hospital with 4-5 days of pain, swelling and redness on her left thumb.

History of Present Illness:

A patient in their mid-60s, with a history of Hashimoto’s thyroiditis using levothyroxine, presents to the hospital with 4 to 5 days of pain, swelling, and redness on her left thumb. She states that the pain is actually slightly better today than it was yesterday. She denies any trauma, fever, or other complaints. She does say about 3 weeks ago she had a small cut in that area that healed uneventfully within 4-5 days. She has no other complaints.

Vital Signs and Physical Exam:

Vital signs are normal. Physical exam is also normal except for the thumb. See image below:

Image of a patient's thumb from a physical exam. | Credit: Brady Pregerson, MD

Credit: Brady Pregerson, MD

Initial Diagnostic Testing:

CBC and Chem-7: Normal

Imaging: Bedside water bath ultrasound shows a slightly hyperechoic mass without shadowing that does not compress. X-ray is shown below.

X-ray image of a patient's thumb. | Credit: Brady Pregerson, MD

X-ray image of a patient's thumb.
Credit: Brady Pregerson, MD

What is the most likely diagnosis?


Related Videos
Marcelo Kugelmas, MD | Credit: South Denver Gastroenterology
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
Eric Lawitz, MD | Credit: UT Health San Antonio
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
© 2024 MJH Life Sciences

All rights reserved.